Idenix Pharma (IDIX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	177.61M
Restricted cash	1.4M
Receivables from related party	1.05M
Other current assets	6.22M
Total current assets	186.29M
Intangible asset, net
Property and equipment, net	2.6M
Restricted cash
Other assets	4.19M
Total assets	197.63M
Accounts payable	7.43M
Accrued expenses	19.67M
Deferred revenue
Deferred revenue, related party	714K
Other current liabilities	449K
Total current liabilities	28.26M
Other long-term liabilities	9.24M
Deferred revenue, net of current portion	4.27M
Deferred revenue, related party, net of current portion	2.92M
Total liabilities	44.69M
Commitments and contingencies (Note 11)	0
Common stock, $0.001 par value; 200,000,000 and 125,000,000 shares authorized at June 30, 2011 and December 31, 2010, respectively; 96,034,826 and 73,091,514 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	151K
Additional paid-in capital	1.08B
Accumulated other comprehensive income	783K
Accumulated deficit	-928.98M
Total stockholders' equity (deficit)	152.94M
Total liabilities and stockholders' equity (deficit)	197.63M

Entities mentioned with IDIX

View All Entities